Domestic COVID drugs added to reimbursement list

2023-02-08 Editor : Li Yan ECNS App Download

The National Healthcare Security Administration said on Wednesday that all domestic COVID-19 medicines have been added to the national medical reimbursement list.

Two newly approved homegrown pills — Xiannuoxin made by Simcere Pharmaceutical Group, and VV116 developed by Shanghai Vinnerna Biosciences — are temporarily covered up until March 31.

Azvudine, the first domestic COVID-19 oral medication developed by Henan Genuine Biotech, was officially included in the last version of the national reimbursement list that was released on Jan 18.

Three traditional Chinese medicine drugs and three herbal formulas have also been added to the list, the administration said.


Most popular in 24h

MoreTop news


Back to top About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2023 All rights reserved.
Reproduction in whole or in part without permission is prohibited.
[网上传播视听节目许可证(0106168)] [京ICP证040655号]
[京公网安备 11010202009201号] [京ICP备05004340号-1]